Evaluation of the Atherogenic Risk of Isotretinoin-induced and Etretinate-induced Alterations of Lipoprotein Cholesterol Metabolism.

This publication has 27 references indexed in Scilit:

• Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for Acne
  New England Journal of Medicine, 1985
• A sequential comparison of etretinate (TigasonR) and isotretinoin (RoaccutaneR) with special regard to their effects on serum lipoproteins
  British Journal of Dermatology, 1985
• Declining cardiovascular mortality.
  Circulation, 1984
• Effect of low dose cyproterone acetate on the response of acne to isotretinoin
  British Journal of Dermatology, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
  JAMA, 1984
• Etretinate therapy causes increases in lipid levels in patients with psoriasis
  Archives of Dermatology, 1982
• Changes in lipid metabolism during retinoid administration
  Journal of the American Academy of Dermatology, 1982
• Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors.
  Journal of Clinical Investigation, 1981
• The influence of Tigason' (Ro 10–9359) on the serum lipoproteins in man
  British Journal of Dermatology, 1981
• Prevalence of coronary heart disease in the framingham offspring study: Role of lipoprotein cholesterols
  The American Journal of Cardiology, 1980